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Epstein—Barr virus (EBV) infection occurs worldwide and
most commonly in early childhood and adolescence. Common
clinical presentations include infectious mononucleosis,
upper respiratory tract infection, diarrhea, and abdominal
complaints.1 We report a case of EBV infection with a rare
manifestation — acute pancreatitis — in an otherwise healthy
patient.
An 18-year-old female was admitted to our hospital with a
4-day history of high-grade fever, sore throat, vomiting,
abdominal pain, and decreased appetite. Her initial physical
examination revealed a temperature of 40.0 8C, a blood
pressure of 83/29 mmHg, mildly injected pharynx and ton-
sils, small bilateral shoddy non-tender cervical lymph nodes,
and generalized abdominal tenderness, especially at the
right upper quadrant area and epigastrium. Laboratory data
revealed a total white blood cell count of 1.9  109/l (66%
band neutrophils, 7% segmental neutrophils, 4% atypical
lymphocytes), hemoglobin of 11.0 g/dl, platelet count of
23  109/l, prothrombin time of 15.2 s, activated partial
thromboplastin time of 82 s, international normalized ratio
(INR) of 1.2, fibrinogen of 80 mg/dl, fibrin degradation pro-
ducts (FDP) of >40 mg/ml, D-dimer of >20 mg/ml, aspartate
aminotransferase of 181 U/l, alanine aminotransferase of
57 U/l, alkaline phosphatase of 97 U/l, total bilirubin of
7.4 mg/dl, amylase of 620 U/l (normal range: 60—180 U/l),
and lipase of 659 U/l (normal range: 0—160 U/l). Ultrasound
of the abdomen showed thickening of the anterior gallblad-
der wall without gallstones. Computed tomography (CT) of
the abdomen and pelvis revealed moderate gallbladder wall
thickening, pericholecystic fluid, edematous pancreas, and
hepatosplenomegaly. A hydroxy iminodiacetic acid (HIDA)
scan, however, did not suggest acute cholecystitis. The pre-
sumptive diagnosis was septic shock with acute pancreatitis
and disseminated intravascular coagulation (DIC). The dif-
ferential diagnoses include systemic viral infections or pri-
mary bone marrow disorders such as lymphoma or
lymphoblastic leukemia. Blood cultures and a urine culture
were taken, and empirical antibiotic therapy consisting ofaztreonam, clindamycin, and moxifloxacin was initiated
given the patient’s history of penicillin allergy. Concerning
her pancytopenia, bone marrow aspiration was performed
and revealed pancytopenia with dyshematopoiesis, increase
in mononuclear cells (approximately 15%), normal blast cell
population, and no evidence of granulomatous inflammation.
Four days after treatment the fever subsided with improve-
ment of abdominal signs. Blood cultures, urine culture, and
bonemarrow culture results were all negative. Viral hepatitis
profiles (A, B, C), HIV RNA, monospot test, and cytomegalo-
virus immunoglobulin M and G were all negative. The diag-
nosis of EBV infection was made by the positive result of EBV
immunoglobulin M and G (VCA, viral capsid antigen) and
immunophenotyping of the bone marrow lymphocytes
(CD4: 12%, CD8: 84%, CD4/CD8 ratio of 0.14 with increased
numbers of CD57-negative CD8 T cells and gamma delta T
cells) consistent with EBV infection. All antibiotics were
discontinued after 4 days of treatment. The patient recov-
ered uneventfully by day 7 after supportive treatment for
pancreatitis.
The gastrointestinal (GI) system is one of the most com-
mon organ systems affected by EBV. Nausea, vomiting, anor-
exia, and abdominal pain are frequently reported symptoms,
probably reflecting mild hepatitis, hepatomegaly, splenome-
galy, and rarely pancreatitis.2
Nine cases of primary EBV infection with pancreatitis have
been reported in the literature (Table 1). In these cases, the
onset of GI symptoms occurred at an average 12 days (range
4—42 days) after the onset of initial constitutional symptoms.
Serum amylase, urine amylase, and clinical presentations are
the important diagnostic tools for acute pancreatitis. Ima-
ging studies, such as CT or ultrasonography of the abdomen
can be used to confirm diagnosis if they are performed late
enough to see gross inflammatory changes of the pancreas.
Symptomatic and supportive treatment was used successfully
in all cases, and the overall outcomes of acute pancreatitis in
the setting of EBV infection were good.3—9
Ourpatient alsohadotherunusual clinical presentations for
EBV infection. Firstly, she presentedwith shockmost likely due
to dehydration and third space fluid loss from acute pancrea-
titis. Secondly, she developed DIC, which can be caused by
either pancreatitis or rarely, EBV itself. Thirdly, she had a
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Table 1 Clinical features of previously published cases of primary EBV infection with pancreatitis
Case
No.
Age
(years)/sex
Underlying
conditions
Initial
clinical
presentation
EBV
diagnosis
GI symptoms Amylasea Lipaseb Imaging Treatment Outcomes Reference
1 10/F None NA EBV
antibody titer,
heterophile
antibody
Epigastric pain,
vomiting
Serum:
5550 U/l
NA USG: normal
pancreas,
distended
gallbladder
with cholelithiasis
Symptomatic
and surgery for
gallstone
NA 3
2 8/F None Fever, sore throat,
myalgia, cervical
lymphadenopathy
EBV antibody
titer,
heterophile
antibody
Epigastric pain,
nausea, vomiting
Serum:
555 U/l
180 U/l NA Symptomatic Cured 4
3 16/M None Fever, sore throat,
cervical
lymphadenopathy
EBV antibody
titer
Epigastric pain,
nausea, vomiting
Serum:
699 U/l
NA USG, CT AB and
oral cholecystogram:
normal
Symptomatic Cured 5
4 18/M None Fever, sore throat,
cervical
lymphadenopathy
Heterophile
antibody,
ox-cell
hemolysin titer
Abdominal pain,
vomiting
Serum:
888 U/l
NA NA Symptomatic Cured 6
5 15/F Infectious
hepatitis 5
months prior
to this illness
Fever, painful
swallowing
EBV antibody
titer
Colicky
abdominal
pain
Urine:
3875 U/l
NA NA Symptomatic Cured 7
6 24/M None Fever, throat pain Monospot,
heterophile
antibody titer
Epigastric pain,
nausea
Serum:
376 U/l
NA NA Symptomatic Cured 8
Urine:
4700 U/l
7 12/F None Fever, sore throat Monospot,
heterophile
antibody titer
Abdominal pain,
nausea
Serum:
703 U/l
NA NA Symptomatic Cured 8
Urine:
8700 U/l
8 23/M Dyspepsia Fever, sore throat,
lymphadenopathy
Heterophile
antibody titer
Nausea,
vomiting
Serum:
271 U/l
417 U/l Oral
cholecystogram:
normal
Symptomatic Cured 9
9 18/F None Fever, sore throat,
cervical
lymphadenopathy
EBV antibody
titer
Abdominal
pain, nausea
Serum:
620 U/l
659 U/l USG and CT AB:
edematous pancreas,
no gallstone
Symptomatic Cured Our case
M, male; F, female; EBV, Epstein—Barr virus; GI, gastrointestinal; NA, not available; USG, ultrasonography of the abdomen; CT AB, computed tomography of the abdomen.
a Serum normal range 60—180 U/l; urine normal range <1600 U/l. The units of all values, if not originally U/l, were converted to U/l for comparison.
b Serum value, normal range 0—160 U/l. The units of all values, if not originally U/l, were converted to U/l for comparison.
Correspondence 229negativemonospot test. The negative result of this test occurs
in about 10% of patients with acute EBV infection due to 90%
sensitivity of the test and delayed appearance of heterophile
antibodies.1 Lastly, she had a thick-walled, tender gallbladder
without gallstones on ultrasonography, suggesting acute cho-
lecystitis. However, this finding is non-specific and can be
found in non-gallbladder diseases including acute viral hepa-
titis, alcoholic hepatitis, pancreatitis, severe malnutrition,
heart failure, and septicemia.10
This reported case suggests that EBV infection can present
with atypical features including acute pancreatitis, hypoten-
sion, DIC, and imaging findings mimicking acute cholecystitis.
A high index of suspicion will facilitate early diagnosis and
prompt treatment of the infection, and prevent unnecessary
antibiotic use.
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